Patents by Inventor Guy Cavet

Guy Cavet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230002480
    Abstract: The present invention provides broadly neutralizing antibodies against HIV, compositions comprising the same and methods of use thereof.
    Type: Application
    Filed: February 22, 2022
    Publication date: January 5, 2023
    Inventors: Mohammad Sajadi, George K. Lewis, Anthony DeVico, Dongkyoon Kim, Guy Cavet
  • Patent number: 11021711
    Abstract: Methods and compositions are provided to determine if a cancer is resistant to treatment with anti-mitotic agents, including treatment with T-DM1. The methods relate to determining if the ABCC3 gene is amplified and/or overexpressed in the cancer.
    Type: Grant
    Filed: December 11, 2017
    Date of Patent: June 1, 2021
    Assignee: GENENTECH, INC.
    Inventors: Mark Lackner, Lukas C. Amler, Guy Cavet, Carol O'Brien, Ajay Pandita
  • Publication number: 20200172601
    Abstract: The present invention provides broadly neutralizing antibodies against HIV, compositions comprising the same and methods of use thereof. Specifically, the invention provides isolated anti-HIV antibodies that are capable of neutralizing at least 95% of the HIV pseudoviruses listed in Table 1 and neutralizing 100% of the HIV clade B, G and D viruses listed in Table 1 with an IC50 value of less than 50 ug/mL. Further provides are the sequences especially complementarity-determining region (CDR) sequences of antibodies disclosed.
    Type: Application
    Filed: June 22, 2018
    Publication date: June 4, 2020
    Inventors: Mohammad Sajadi, George K. Lewis, Anthony DeVico, Amir Dashti, Marzena E. Pazgier, William David Tolbert, Dongkyoon Kim, Guy Cavet
  • Publication number: 20180298387
    Abstract: Methods and compositions are provided to determine if a cancer is resistant to treatment with anti-mitotic agents, including treatment with T-DM1. The methods relate to determining if the ABCC3 gene is amplified and/or overexpressed in the cancer.
    Type: Application
    Filed: December 11, 2017
    Publication date: October 18, 2018
    Inventors: Mark Lackner, Lukas C. Amler, Guy Cavet, Carol O'Brien, Ajay Pandita
  • Patent number: 9879267
    Abstract: Methods and compositions are provided to determine if a cancer is resistant to treatment with anti-mitotic agents, including treatment with T-DM1. The methods relate to determining if the ABCC3 gene is amplified and/or overexpressed in the cancer.
    Type: Grant
    Filed: March 12, 2009
    Date of Patent: January 30, 2018
    Assignee: Genentech, Inc.
    Inventors: Mark Lackner, Lukas C. Amler, Guy Cavet, Carol O'Brien, Ajay Pandita
  • Patent number: 8457903
    Abstract: Computer processing methods and/or systems for minimizing and/or optimizing data strings in accordance with rules and options. Minimized data strings can represent data sequences important in certain biologic analyses and/or syntheses. In specific embodiments, a request is generated by a user at a client system and received by a server system. The server system accesses initial data indicated or provided by the client system. The server system then performs an analysis to minimize the data needed for further reactions. In specific embodiments, a server can use proprietary methods or data at the server side while protecting those proprietary methods and data from access by the client system.
    Type: Grant
    Filed: September 9, 2011
    Date of Patent: June 4, 2013
    Assignee: Codexis Mayflower Holdings, LLC
    Inventors: Robin A. Emig, Richard John Fox, Claes Gustafsson, Sridhar Govindarajan, Jeremy S. Minshull, Guy Cavet
  • Publication number: 20110177099
    Abstract: Methods and compositions are provided to determine if a cancer is resistant to treatment with anti-mitotic agents, including treatment with T-DM1. The methods relate to determining if the ABCC3 gene is amplified and/or overexpressed in the cancer.
    Type: Application
    Filed: March 12, 2009
    Publication date: July 21, 2011
    Inventors: Mark Lackner, Lukas C. Amler, Guy Cavet, Carol O'Brien, Ajay Pandita
  • Patent number: 7702464
    Abstract: Computer processing methods and/or systems for minimizing and/or optimizing data strings in accordance with rules and options. Minimized data strings can represent data sequences important in certain biologic analyses and/or syntheses. In specific embodiments, a request is generated by a user at a client system and received by a server system. The server system accesses initial data indicated or provided by the client system. The server system then performs an analysis to minimize the data needed for further reactions. In specific embodiments, a server can use proprietary methods or data at the server side while protecting those proprietary methods and data from access by the client system.
    Type: Grant
    Filed: August 30, 2002
    Date of Patent: April 20, 2010
    Assignee: Maxygen, Inc.
    Inventors: Robin A. Emig, Richard John Fox, Claes Gustafsson, Sridhar Govindarajan, Jeremy S. Minshull, Guy Cavet